AMY FREEMAN: Open Payments
NPI 1174062947 · LAVONIA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,140 in 75 payments from 17 companies in 2025. Trend: 2023 $986 · 2024 $1,001 · 2025 $1,140
Food & beverage: $1,140
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 26 | $227 |
| AstraZeneca Pharmaceuticals LP | 10 | $176 |
| Novo Nordisk Inc | 8 | $151 |
| Otsuka America Pharmaceutical, Inc. | 7 | $141 |
| PFIZER INC. | 4 | $77 |
| Axsome Therapeutics, Inc. | 4 | $65 |
| Biogen, Inc. | 2 | $51 |
| Exact Sciences Corporation | 3 | $47 |
| Amgen Inc. | 2 | $36 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $35 |
Products named: VRAYLAR, REXULTI, NURTEC ODT, Ozempic, AIRSUPRA, FARXIGA, Auvelity, Wegovy.
Industry payments across GA — which companies pay providers there.
